Sanofi Xyzal OTC Antihistamine Claims Lose Second Challenge In Six Months
This article was originally published in The Pink Sheet & The Rose Sheet
Executive Summary
Sanofi will modify claims in social media ads that its Xyzal Allergy 24HR antihistamine is 'twice as fast' as Bayer's s Claritin after the US National Advertising Division found the statement is not supported by head-to-head testing. NAD also recommended the firm discontinue the claim the product provides “relief that starts at hour 1 instead of hour 2.”